HC wainwright Upgrades MoonLake Immunotherapeutics to Buy From Neutral
MoonLake Immunotherapeutics (MLTX) has an average rating of overweight and mean price target of $14.13, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic rese
